Overview

Eye Health Supplements Market is estimated to value over 10.6 billion by 2027 end with a CAGR of over 6.2% during the forecast period 2020 to 2027.

Growing number of patients getting diagnosed with eye disorders like age-related macular degeneration, rising awareness pertaining to eye diseases among general population are some important factors responsible for the eye health supplements market growth. Furthermore, many market players are expanding their product line ups by accepting various strategies for formulations and product launches that are emphasized on eye diseases. Such factors shall boost the proliferation of the market. Moreover, key players are accepting newer formulation technologies for enhancing the bioavailability of the respective ingredients. Carotenoids like beta-carotene, astaxanthin and lutein generally have lesser ingredient bioavailability. Pills, tablets and capsules are generally used as supplements for eye health. However, very few key players are attempting to explore innovative supplement formulations for eye care, thereby bolstering the proliferation of the market.

Eye Health Supplements Market Segmentation:

By Ingredient Type
•    Lutein and Zeaxanthin
•    Antioxidants  
•    Omega-3 Fatty Acids
•    Coenzyme Q 10
•    Flavonoids  
•    Astaxanthin 
•    Alpha-Lipoic Acid
•    Others
By Disease Indication
•    Age-Related macular Degeneration 
•    Cataract
•    Dry Eye Syndrome 
•    Others
By Form 
•    Tablet
•    Capsule
•    Others
By Region
•    North America
•    Europe 
•    Asia Pacific
•    Latin America
•    Middle East & Africa

The market is divided into ingredient type, disease indication, by form and by region. The ingredient type segment is categorised into lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme Q 10, flavonoids, astaxanthin, alpha-lipoic acid and other ingredients. The disease indication segment is diversified into cataract, dry eye syndrome and other indications while the form segment is categorised into tablet, capsule and other forms.

Regional Analysis:

The North America region is expected to dominate the market owing to the rising occurrence of appalling eye disorders, growing geriatric population, improvements in the reimbursement policies, growing awareness pertaining to eye disorders. Furthermore, a strong presence of major market players along with the availability of novel commercialised supplements shall boost the market growth in the region.

Competitive Landscape:                            

Some of the key market players associated are Vitabiotics Ltd., Pfizer Inc., Bausch Health Companies Inc., Novartis AG, Amway Corp., Alliance Pharma, The Nature's Bounty Co., EyeScience (U.S.), Orthomol (Germany), Efamol Ltd (U.K.).

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global eye health supplements market by ingredient type, by disease indication, by form and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
          1.1 Objectives of the Study 
          1.2 Market Definition 
          1.3 Market Scope 
                1.3.1 Years Considered for the Study
                1.3.2 Market Covered
          1.4 Currency
          1.5 Limitations 
          1.6 Stakeholders 
 2.  Research Methodology 
          2.1 Research Data 
                2.1.1 Secondary Data
                         2.1.1.1 Key Data from Secondary Sources
                 2.1.2 Primary Data
                         2.1.2.1 Key Data from Primary Sources
          2.2 Market Size Estimation 
          2.3 Market Breakdown and Data Triangulation 
          2.4 Assumptions for the Study  
3. Executive Summary
          3.1 Market Outlook
          3.2 Segment Outlook
          3.3 Competitive Insights
4. Market Variables, Trends & Scope
          4.1 Market Lineage Outlook
          4.2 Penetration and Growth Prospect Mapping
          4.3 Industry Value Chain Analysis
          4.4 Cost Analysis Breakdown
          4.5 Technology Overview
          4.6 Regulatory Framework on Country Level
                 4.6.1 Reimbursement Framework    
                 4.6.2 Standards and Compliances
5. Market Overview
        5.1 Market Dynamics
                 5.1.1 Market Driver Analysis
                 5.1.2 Market Restraint Analysis
                 5.1.3 Industry Challenges                   
6. Market Analysis tools
        6.1 Industry Analysis - Porter’s
                     6.1.1 Supplier Power
                     6.1.2 Buyer Power
                     6.1.3 Substitution Threat
                     6.1.4 Threat from new entrants
                     6.1.5 Competitive Rivalry
         6.2 Pestel Analysis
                     6.2.1 Political Landscape
                     6.2.2 Environmental Landscape
                     6.2.3 Social landscape
                     6.2.4 Technology landscape
                     6.2.5 Legal Landscape
7. Eye Health Supplements Market, By Ingredient Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         7.1 Lutein and Zeaxanthin
         7.2 Antioxidants
         7.3 Omega-3 Fatty Acids
         7.4 Coenzyme Q 10
         7.5 Flavonoids 
         7.6 Astaxanthin
8. Eye Health Supplements Market, By Disease Indication Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         8.1 Age-Related macular Degeneration
         8.2 Cataract
         8.3 Dry Eye Syndrome
         8.4 Others
9. Eye Health Supplements Market, By Distribution Channel Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Tablet
         9.2 Capsule
         9.3 Others
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                10.2.1. U.S.
                10.2.2. Canada
                10.2.3. Mexico
                10.2.4 Rest of North America
         10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Regional Market Trends
         11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                11.3.1. Brazil
                11.3.2. Uruguay
                11.3.3 Argentina
                11.3.4. Rest of Latin America
         11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.2.1. Germany
                12.2.2. U.K
                12.2.3. France
                12.2.4. Italy
                12.2.5 Switzerland
                12.2.6. Spain
                12.2.7. Russia
                12.2.8. Poland
                12.2.9. Rest of Western Europe
          12.3 Market Size (US$ Mn) Forecast for North America 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          13.1 Introduction
          13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 13.2.1 Japan
                 13.2.2 China
                 13.2.3 Singapore
                 13.2.4 Korea         
                 13.2.5 India
                 13.2.6 Australia and New Zealand
                 13.2.7 ASEAN
                 13.2.8 Rest of Asia Pacific
         13.3 Market Size (US$ Mn) Forecast for North America 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          14.1 Introduction
          14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
              14.2.1 UAE
              14.2.2 South Africa
              14.2.3 Egypt
              14.2.4 Saudi Arabia
              14.2.5 Rest of MEA
    14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
     15.1 Vitabiotics Ltd.
             15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.1.2. Product Portfolio
             15.1.3. SWOT Analysis
             15.1.4. Financial Overview
             15.1.5. Strategic Overview
    15.2 Pfizer Inc.
             15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.2.2. Product Portfolio
             15.2.3. SWOT Analysis
             15.2.4. Financial Overview
             15.2.5. Strategic Overview
     15.3 Bausch Health Companies Inc.
             15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.3.2. Product Portfolio
             15.3.3. SWOT Analysis
             15.3.4. Financial Overview
             15.3.5. Strategic Overview
     15.4 Novartis AG
             15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.4.2. Product Portfolio
             15.4.3. SWOT Analysis
             15.4.4. Financial Overview
             15.4.5. Strategic Overview
      15.5 Amway Corp.
             15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.5.2. Product Portfolio
             15.5.3. SWOT Analysis
             15.5.4. Financial Overview
             15.5.5. Strategic Overview
      15.6 Alliance Pharma
             15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.6.2. Product Portfolio
             15.6.3. SWOT Analysis
             15.6.4. Financial Overview
             15.6.5. Strategic Overview
      15.7 The Nature's Bounty Co. 
             15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.7.2. Product Portfolio
             15.7.3. SWOT Analysis
             15.7.4. Financial Overview
             15.7.5. Strategic Overview
     15.8 EyeScience (U.S.)
             15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.8.2. Product Portfolio
             15.8.3. SWOT Analysis
             15.8.4. Financial Overview
             15.8.5. Strategic Overview
     15.9 Orthomol (Germany)
             15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.9.2. Product Portfolio
             15.9.3. SWOT Analysis
             15.9.4. Financial Overview
             15.9.5. Strategic Overview
     15.10 Efamol Ltd (U.K.)
             15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
             15.10.2. Product Portfolio
             15.10.3. SWOT Analysis
             15.10.4. Financial Overview
             15.10.5. Strategic Overview
16 Impact of COVID-19
      16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations
17 Competitive Intelligence and Competitive Matrix
      17.1 Competitive Intelligence
      17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
      18.1 Joint ventures
      18.2 Mergers and acquisitions
      18.3 Licensing and partnerships 
      18.4 Technology Collaborations
      18.5 Strategic Divestments
      18.6 Market Entry Strategies
19. Relevant Case Studies and Latest News Updates    
20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Tables

Figures